Literature DB >> 19738058

c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner.

Bing Yu1, Ze-Hong Miao, Yi Jiang, Mei-Hong Li, Na Yang, Ting Li, Jian Ding.   

Abstract

Although hypoxia-inducible factor-1alpha (HIF-1alpha) has long been intensively investigated as a drug target by interfering with its expression or transcriptional function, the regulatory mechanisms of HIF-1alpha remain to be further clarified. We report here that c-Jun associates with HIF-1alpha via its oxygen-dependent degradation domain, masks the sites for ubiquitination, and thus protects HIF-1alpha from proteasome-executing degradation. All of these together resulted in the stabilization and accumulation of HIF-1alpha, consequently promoting the transcription of its target gene and driving angiogenesis-related events. The stabilization of HIF-1alpha was dependent on the domains of c-Jun for DNA binding and heterodimerization but independent of the Ser(63/73) phosphorylation that is critical for transcriptional function. These findings highlight a previously unrecognized nontranscriptional function of c-Jun on the one hand and a distinct regulatory mechanism of HIF-1alpha activity on the other, consequently offering profound mechanistic insights into multiple events simultaneously involving both c-Jun and HIF-1alpha in tumor progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19738058     DOI: 10.1158/0008-5472.CAN-09-0808

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  25 in total

1.  Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model.

Authors:  Bing Yu; Mei-Hong Li; Wei Wang; Ying-Qing Wang; Yi Jiang; Sheng-Ping Yang; Jian-Min Yue; Jian Ding; Ze-Hong Miao
Journal:  J Mol Med (Berl)       Date:  2012-03-10       Impact factor: 4.599

2.  Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.

Authors:  Shuyan Meng; Guorui Wang; Yang Lu; Zhen Fan
Journal:  Lung Cancer       Date:  2018-05-01       Impact factor: 5.705

3.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

4.  Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis.

Authors:  Zhongdong Hu; Ying Wang; Fuqiang Huang; Rongrong Chen; Chunjia Li; Fang Wang; June Goto; David J Kwiatkowski; Joanna Wdzieczak-Bakala; Pengfei Tu; Jianmiao Liu; Xiaojun Zha; Hongbing Zhang
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

5.  c-Jun promotes the survival of H9c2 cells under hypoxia via PTEN/Akt signaling pathway.

Authors:  Fan Wu; Feng Gao; Siyi He; Yunhan Jiang; Guiping Luo; Yingbin Xiao
Journal:  J Physiol Biochem       Date:  2019-08-03       Impact factor: 4.158

6.  Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.

Authors:  Zhao-Li Zhou; Zhi-Guo Luo; Bing Yu; Yi Jiang; Yi Chen; Jian-Ming Feng; Mei Dai; Lin-Jiang Tong; Zheng Li; Yuan-Chao Li; Jian Ding; Ze-Hong Miao
Journal:  Mol Cancer       Date:  2010-10-11       Impact factor: 27.401

Review 7.  Newly discovered angiogenesis inhibitors and their mechanisms of action.

Authors:  Ze-hong Miao; Jian-ming Feng; Jian Ding
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

8.  Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways.

Authors:  Douglas N Clarke; Abraham Al Ahmad; Boyeon Lee; Christi Parham; Lisa Auckland; Andrezj Fertala; Michael Kahle; Courtney S Shaw; Jill Roberts; Gregory J Bix
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

9.  Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors.

Authors:  Y Piña; C Decatur; Tg Murray; Sk Houston; D Gologorsky; M Cavalcante; L Cavalcante; E Hernandez; M Celdran; W Feuer; T Lampidis
Journal:  Clin Ophthalmol       Date:  2011-03-07

10.  Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death.

Authors:  Alice Y W Chang
Journal:  J Biomed Sci       Date:  2012-11-17       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.